Singapore Medical Group to delist from SGX-ST

It will delist on 20 January.

Singapore Medical Group (SMG) will delist from the Catalist board of the SGX-ST on 20 January at 9 a.m.

The delisting announcement came after its privatisation last month.

In December 2022, TLW Success received 95.14 per cent of valid acceptances for its offer to acquire all the issued and paid-up ordinary shares in SMG.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia